Anika Therapeutics
ANIK
ANIK
122 hedge funds and large institutions have $324M invested in Anika Therapeutics in 2024 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 35 increasing their positions, 49 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
0.62% less ownership
Funds ownership: 89.09% → 88.47% (-0.62%)
4% less capital invested
Capital invested by funds: $335M → $324M (-$11.8M)
29% less repeat investments, than reductions
Existing positions increased: 35 | Existing positions reduced: 49
Holders
122
Holding in Top 10
4
Calls
$5K
Puts
$5K
Top Buyers
| 1 | +$3.9M | |
| 2 | +$2.15M | |
| 3 | +$607K | |
| 4 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$591K |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$443K |
Top Sellers
| 1 | -$1.89M | |
| 2 | -$1.45M | |
| 3 | -$1.21M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$1.16M |
| 5 |
VIA
Virtus Investment Advisers
Hartford,
Connecticut
|
-$1.15M |